This grant application is focused on elucidating the molecular basis of clinical resistance to HIV-1 PR inhibitors. Resistant mutants of HIV-1 PR show lower affinity for inhibitors, yet are still able to process viral polyprotein substrates in the course of viral replication. The amino acid sequences of resistant mutants are known from clinical studies. In order to elucidate the molecular basis of resistance to HIV-1 protease inhibitors, the complete binding energetics of substrate and inhibitors to the HIV-1 PR (wt; resistance mutants) will be measured by high sensitivity reaction calorimetric techniques and standard spectroscopic assays. Structure-based thermodynamic analysis will be performed using a novel approach developed in the applicant's laboratory. This information will be used to develop a structural map of the binding energetics of substrates and inhibitors. The structural map will identify the energetic contributions from each group in the protease, substrate or inhibitor molecules to the overall binding affinity. This map will also identify enthalpic and entropic contributions to the binding energetics, and dissect the entropy contributions into conformation and solvent-related components. Differences in the type and strength of interactions will be evaluated and used to identify why some specific mutations affect the binding affinity of the substrate and inhibitor in different ways.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM057144-02
Application #
2883068
Study Section
AIDS and Related Research Study Section 4 (ARRD)
Project Start
1998-03-01
Project End
2001-02-28
Budget Start
1999-03-01
Budget End
2000-02-29
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Chauhan, Jay; Chen, Shen-En; Fenstermacher, Katherine J et al. (2015) Synthetic, structural mimetics of the ?-hairpin flap of HIV-1 protease inhibit enzyme function. Bioorg Med Chem 23:7095-109
Velazquez-Campoy, Adrian; Leavitt, Stephanie A; Freire, Ernesto (2015) Characterization of protein-protein interactions by isothermal titration calorimetry. Methods Mol Biol 1278:183-204
Evans, Sean L; Schön, Arne; Gao, Qimeng et al. (2014) HIV-1 Vif N-terminal motif is required for recruitment of Cul5 to suppress APOBEC3. Retrovirology 11:4
Miura, Takuya; Hidaka, Koushi; Azai, Yukiko et al. (2014) Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum. Bioorg Med Chem Lett 24:1698-701
Afanador, Gustavo A; Muench, Stephen P; McPhillie, Martin et al. (2013) Discrimination of potent inhibitors of Toxoplasma gondii enoyl-acyl carrier protein reductase by a thermal shift assay. Biochemistry 52:9155-66
Thanigaimalai, Pillaiyar; Konno, Sho; Yamamoto, Takehito et al. (2013) Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: structure-activity relationship study. Eur J Med Chem 65:436-47
Liu, Yingyun; Schön, Arne; Freire, Ernesto (2013) Optimization of CD4/gp120 inhibitors by thermodynamic-guided alanine-scanning mutagenesis. Chem Biol Drug Des 81:72-8
Thanigaimalai, Pillaiyar; Konno, Sho; Yamamoto, Takehito et al. (2013) Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studies. Eur J Med Chem 68:372-84
Resendiz, Marino J E; Schon, Arne; Freire, Ernesto et al. (2012) Photochemical control of RNA structure by disrupting ýý-stacking. J Am Chem Soc 134:12478-81
Schon, Arne; Lam, Sonia Y; Freire, Ernesto (2011) Thermodynamics-based drug design: strategies for inhibiting protein-protein interactions. Future Med Chem 3:1129-37

Showing the most recent 10 out of 29 publications